NORMALIZATION OF PHENOTYPE AND REDUCTION OF GLIOSIS LEVELS VIA GLUTAMINYL CYCLASES INHIBITION IN A HUNTINGTON DISEASE MOUSE MODEL

Plank AC, Schilling S, Hoffmann T, Lues I, von Hörsten S (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Journal of Neurology Neurosurgery and Psychiatry BMJ Publishing Group

Book Volume: 89

Pages Range: A95-A95

DOI: 10.1136/jnnp-2018-ehdn.255

Authors with CRIS profile

Anne-Christine Plank Professur für Experimentelle Biomedizin Stephan von Hörsten Professur für Experimentelle Biomedizin

Involved external institutions

Probiodrug AG DE Germany (DE) Fraunhofer-Institut für Zelltherapie und Immunologie (IZI) DE Germany (DE)

How to cite

APA:

Plank, A.-C., Schilling, S., Hoffmann, T., Lues, I., & von Hörsten, S. (2018). NORMALIZATION OF PHENOTYPE AND REDUCTION OF GLIOSIS LEVELS VIA GLUTAMINYL CYCLASES INHIBITION IN A HUNTINGTON DISEASE MOUSE MODEL. (pp. A95-A95).

MLA:

Plank, Anne-Christine, et al. "NORMALIZATION OF PHENOTYPE AND REDUCTION OF GLIOSIS LEVELS VIA GLUTAMINYL CYCLASES INHIBITION IN A HUNTINGTON DISEASE MOUSE MODEL." 2018. A95-A95.

BibTeX: Download